Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer

Y Shimada, S Okuda, Y Watanabe, Y Tajima… - Journal of …, 2021 - Springer
Background Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …

Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer

Y Shimada, S Okuda, Y Watanabe… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …

Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer.

Y Shimada, S Okuda, Y Watanabe… - Journal of …, 2021 - europepmc.org
Background Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …

Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer

Y Shimada, S Okuda, Y Watanabe… - Journal of …, 2021 - kyushu-u.elsevierpure.com
Background: Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …

[引用][C] Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer

Y Shimada, S Okuda, Y Watanabe, Y Tajima… - Journal of …, 2021 - cir.nii.ac.jp
Histopathological characteristics and artificial intelligence for predicting tumor mutational
burden-high colorectal cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer

Y Shimada, S Okuda, Y Watanabe… - Journal of …, 2021 - pure.fujita-hu.ac.jp
Background: Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …

Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer

Y Shimada, S Okuda, Y Watanabe… - Journal of …, 2021 - pure.fujita-hu.ac.jp
Background: Tumor mutational burden-high (TMB-H), which is detected with gene panel
testing, is a promising biomarker for immune checkpoint inhibitors (ICIs) in colorectal cancer …